Considering the pleiotropic roles of PLK1 in many cellular pathways whose involvement in cancer has been clearly demonstrated, PLK1 is a potential therapeutic target and in the last decade various PLK1 inhibitors have been developed by drug companies and academic research groups. The gene discussed is PLK1; the disease is cancer.